Trial
NCT05139056
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
Phase ISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Currently Only Enrolling Glioblastoma Patients at First Recurrence
Intervention
Neural Stem Cells-expressing CRAd-S-pk7
Why stopped
Safety issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-27